Notable Labs Return on Investment 2013-2024 | NTBLQ
Current and historical return on investment (ROI) values for Notable Labs (NTBLQ) over the last 10 years.
Notable Labs ROI - Return on Investment Historical Data |
Date |
TTM Net Income |
LT Investments & Debt |
Return on Investment |
2024-06-30 |
$-0.02B |
$0.01B |
-176.47% |
2024-03-31 |
$-0.01B |
$0.01B |
-192.59% |
2023-12-31 |
$-0.02B |
$0.02B |
-400.00% |
2023-09-30 |
$0.01B |
|
inf% |
2023-06-30 |
$-0.00B |
|
inf% |
2023-03-31 |
$-0.01B |
|
inf% |
2022-12-31 |
$-0.01B |
|
inf% |
2022-09-30 |
$-0.04B |
|
inf% |
2022-06-30 |
$-0.04B |
|
inf% |
2022-03-31 |
$-0.04B |
|
inf% |
2021-12-31 |
$-0.03B |
|
inf% |
2021-09-30 |
$-0.03B |
|
inf% |
2021-06-30 |
$-0.03B |
|
inf% |
2021-03-31 |
$-0.03B |
|
inf% |
2020-12-31 |
$-0.03B |
|
inf% |
2020-09-30 |
$-0.02B |
|
-266.67% |
2020-06-30 |
$-0.02B |
|
-255.56% |
2020-03-31 |
$-0.02B |
|
-244.44% |
2019-12-31 |
$-0.02B |
$0.04B |
-222.22% |
2019-09-30 |
$-0.02B |
|
inf% |
2019-06-30 |
$-0.02B |
|
inf% |
2019-03-31 |
$-0.02B |
|
inf% |
2018-12-31 |
$-0.02B |
|
inf% |
2018-09-30 |
$-0.03B |
|
inf% |
2018-06-30 |
$-0.03B |
|
inf% |
2018-03-31 |
$-0.03B |
|
inf% |
2017-12-31 |
$-0.02B |
|
inf% |
2017-09-30 |
$-0.02B |
|
inf% |
2017-06-30 |
$-0.02B |
|
inf% |
2017-03-31 |
$-0.02B |
|
inf% |
2016-12-31 |
$-0.02B |
|
inf% |
2016-09-30 |
$-0.01B |
|
inf% |
2016-06-30 |
$-0.02B |
|
inf% |
2016-03-31 |
$-0.02B |
|
inf% |
2015-12-31 |
$-0.02B |
|
inf% |
2015-09-30 |
$-0.02B |
|
inf% |
2015-06-30 |
$-0.01B |
|
inf% |
2015-03-31 |
$-0.01B |
|
inf% |
2014-12-31 |
$-0.01B |
|
inf% |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
MED-BIOMED/GENE |
$0.000B |
$0.000B |
Notable Labs Ltd. is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Notable Labs Ltd., formerly known as Vascular Biogenics Ltd., is based in FOSTER CITY, Calif.
|